Federal award
KBR WYLE SERVICES, LLC
0218
Contract
Obligated and Ceiling
- Obligated (net)
- $29,653,815.42
- Ceiling (potential value, not spending)
- $48,183,120.00
- Current value
- $48,183,120.00
- Gross positive obligations
- $36,867,163.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0218
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 40 · Sep 30, 2011 to Jan 16, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History40
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 16, 2019 | FY2019 | 1E | C | −$442,579.58 | |
| Feb 21, 2018 | FY2018 | 1D | C | −$743,184.05 | |
| Mar 22, 2017 | FY2017 | 1C | C | −$168,638.00 | |
| Oct 26, 2016 | FY2017 | 1B | C | −$1,235,251.18 | |
| Jun 3, 2016 | FY2016 | 35 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 1, 2016 | FY2016 | 1A | C | −$2,028,775.77 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 11, 2016 | FY2016 | 34 | C | $1,253,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 31, 2015 | FY2015 | 33 | C | −$29,604.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 24, 2015 | FY2015 | 32 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 13, 2015 | FY2015 | 31 | C | $2,526,442.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 22, 2015 | FY2015 | 30 | C | $500,495.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 23, 2015 | FY2015 | 29 | B | −$1,551,594.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 25, 2015 | FY2015 | 28 | C | $345,191.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 12, 2015 | FY2015 | 27 | C | $1,352,332.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 15, 2014 | FY2014 | 26 | B | $250,952.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 6, 2014 | FY2014 | 25 | C | $79,200.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 12, 2014 | FY2014 | 24 | C | $247,036.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 27, 2014 | FY2014 | 22 | C | $170,986.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 25, 2013 | FY2013 | 21 | C | $1,581,579.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 12, 2013 | FY2013 | 20 | C | $347,391.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 5, 2013 | FY2013 | 19 | C | $1,842,739.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 21, 2013 | FY2013 | 18 | C | $29,604.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 29, 2013 | FY2013 | 17 | C | $195,005.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 4, 2013 | FY2013 | 16 | C | $539,604.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 2, 2013 | FY2013 | 15 | C | $136,002.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 27, 2012 | FY2013 | 14 | C | $88,630.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 29, 2012 | FY2012 | 13 | C | $753,262.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 27, 2012 | FY2012 | 12 | M | −$1,013,721.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 16, 2012 | FY2012 | 11 | C | $1,382,359.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 7, 2012 | FY2012 | 10 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 7, 2012 | FY2012 | 9 | C | $1,182,359.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 2, 2012 | FY2012 | 8 | C | $89,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 19, 2012 | FY2012 | 7 | C | $5,018,176.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 21, 2012 | FY2012 | 6 | M | $2,150,848.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 24, 2012 | FY2012 | 5 | C | $993,049.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 11, 2012 | FY2012 | 4 | C | $3,510,227.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 2, 2012 | FY2012 | 3 | C | $598,569.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 23, 2012 | FY2012 | 2 | C | $1,290,963.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 2, 2011 | FY2012 | 1 | C | $112,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 30, 2011 | FY2011 | 0 | — | $8,300,163.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.